Buruli ulcer

Global Buruli Ulcer Initiative events

WHO FIND consultative meeting on diagnostics for buruli ulcer
Geneva 21 November 2013

Infection with Mycobacterium ulcerans has been documented in more than 33 countries worldwide. The majority of cases are in Sub-Saharan Africa, although the disease also occurs in other regions such as South-East Asia, South America and Western Pacific.

The causative organism of BU is Mycobacterium ulcerans but the modes of transmission have not been identified.

Differents diagnostic tests are currently available for BU.

WHO Meeting on Buruli ulcer Control and Research
25–27 March 2013 | Geneva, Switzerland

WHO regularly organizes a general meeting in Geneva that brings together representatives from the ministries of health of the affected countries, nongovernmental organizations and research institutions involved in Buruli ulcer (BU) activities to encourage the exchange of new scientific and public health information on the disease, and to coordinate efforts among all partners. The last meeting was held from 25 to 27 March 2013 at the WHO Headquarters in Geneva, Switzerland.

The objectives of this meeting were:

  • To review the epidemiological situation in endemic countries (2011–2012);
  • To share information on activities carried out on Buruli ulcer control and research, and achievements made;
  • To agree on control and research priorities for the next 2 years, and coordinate their implementation.

About 200 participants from 30 countries attended the meeting.

Buruli in the news!

28 August 2014 | Geneva
Read 10 facts on Buruli ulcer

31 July 2014 | Geneva
Simple test promises early diagnosis of debilitating skin disease

10 July 2014 | Geneva
Clinical epidemiology of laboratory-confi rmed Buruli ulcer in Benin: a cohort
The Lancet , Vol 2 July 2014

20 June 2014 | Geneva
Management of BU–HIV co-infection
Tropical Medicine & International Health, DOI: 10.1111/tmi.12342

18 June 2014 | Geneva
Good data collection is essential for a better understanding of Buruli ulcer
The Lancet Global health, Vol 2, Issue 7

02 January 2014 | Geneva
Accelerated Detection of Mycolactone Production and Response to Antibiotic Treatment in a Mouse Model of Mycobacterium ulcerans Disease.
PloSntds DOI: 10.1371/journal.pntd.0002618

Laboratory confirmation
Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease)